Favipiravir Inhibits Mayaro Virus Infection in Mice (original) (raw)
In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease
Mânlio Tasso Mota
Scientific Reports, 2020
View PDFchevron_right
Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
Donald Smee
PLoS Neglected Tropical Diseases, 2011
View PDFchevron_right
Mayaro virus replication restriction and induction of muscular inflammation in mice are dependent on age and type-I interferon response
Claudia Pinto Figueiredo
2019
View PDFchevron_right
Favipiravir (T-705) protects against Nipah virus infection in the hamster model
Terry Juelich
Scientific reports, 2018
View PDFchevron_right
F1000Prime recommendation of Favipiravir (T-705) protects against Nipah virus infection in the hamster model
Branka Horvat
F1000 - Post-publication peer review of the biomedical literature, 2019
View PDFchevron_right
Evaluation of expression of messenger RNA (RNAm) of the key proteins of the route of the microRNA (miRNA) in RD cells infected with the Mayaro Virus
Samir Casseb
Research, Society and Development, 2021
View PDFchevron_right
A Review on Antiviral Activity of Favipiravir
Akash Marathakam
Journal of Pharmaceutical Research International, 2022
View PDFchevron_right
Real-time RT-PCR for Mayaro virus detection in plasma and urine
alejandra hernandez rojas
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2017
View PDFchevron_right
Mayaro Virus Infects Human Brain Cells and Induces a Potent Antiviral Response in Human Astrocytes
Dorothée Missé
Viruses
View PDFchevron_right
An emerging public health threat: Mayaro virus increases its distribution in Peru
Luis J. del Valle
International Journal of Infectious Diseases
View PDFchevron_right
Favipiravir: A Critical Review of Pharmacology, Pre-Clinical Data, and Emerging Clinical Uses in COVID-19
IJRASET Publication
IJRASET, 2021
View PDFchevron_right
Madsen et al Antiviral Research 2014.pdf
Jonathan Dinman
View PDFchevron_right
T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture
Donald Smee
Antimicrobial Agents and Chemotherapy, 2011
View PDFchevron_right
DRUG REVIEW: FAVIPIRAVIR
Shreya Talreja, Prof Dr Shashank Tiwari
Ciencia and Engenharia/ Science and Engineering Journal , 2020
View PDFchevron_right
Mayaro Virus Pathogenesis and Transmission Mechanisms
Dorothée Missé
Pathogens, 2020
View PDFchevron_right
Mayaro virus; a neglected threat could cause the next worldwide viral epidemic
Mânlio Tasso Mota
Future Virology, 2019
View PDFchevron_right
Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models
Donald Smee
Antiviral Research, 2010
View PDFchevron_right
Macrophages as target cells for Mayaro virus infection: involvement of reactive oxygen species in the inflammatory response during virus replication
Leandro Silva da Costa
Anais da Academia Brasileira de Ciências, 2016
View PDFchevron_right
Long-Term Arthralgia after Mayaro Virus Infection Correlates with Sustained Pro-inflammatory Cytokine Response
Stalin Fran Vilcarromero Llaja
PLoS neglected tropical diseases, 2015
View PDFchevron_right
Comparison of remdesivir and favipiravir - the anti-Covid-19 agents mimicking purine RNA constituents
Naser Al Tannak
Biomedical Papers, 2022
View PDFchevron_right
In Vitro and In Vivo Activity of Ribavirin against Andes Virus Infection
David Safronetz
PLoS ONE, 2011
View PDFchevron_right
Antiviral activity of Favipiravir (T-705) against a broad range of paramyxoviruses in vitro and against Human Metapneumovirus in hamsters
B. Van Den Hoogen
Antimicrobial agents and chemotherapy, 2016
View PDFchevron_right
Essential role of the CCL2-CCR2 axis in Mayaro virus-induced disease
Simone de Araújo
View PDFchevron_right
Mayaro virus: a neglected arbovirus of the Americas
Joselyn Vargas
View PDFchevron_right
Favipiravir: A new and emerging antiviral option in COVID-19
Umang Agrawal
Medical Journal Armed Forces India, 2020
View PDFchevron_right
Combination Chemotherapy of Punta Toro Virus Infections in Mice Using Ribavirin and 7-thia-8-oxoguanosine
Donald Smee
Antiviral Chemistry and Chemotherapy
View PDFchevron_right
Favipiravir, will it be the Answer for the Specific Management of COVID-19?: A Review
jayant patharkar
Medico-Legal Update, 2021
View PDFchevron_right
Favipiravir (T-705) inhibits in vitro norovirus replication
Dirk Jochmans
Biochemical and Biophysical Research Communications, 2012
View PDFchevron_right
Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome
David Safronetz
Antimicrobial Agents and Chemotherapy, 2013
View PDFchevron_right
Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
Lisa Oestereich
PLoS Neglected Tropical Diseases, 2014
View PDFchevron_right
Everything you wanted to know about Mayaro virus but were afraid to ask: Characterization and lifecycle of Mayaro virus in vertebrate and invertebrate cellular backgrounds
Sujit Pujhari
2020
View PDFchevron_right
Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
Sabrina Kali
Viruses, 2018
View PDFchevron_right
Role of favipiravir in the treatment of COVID-19
abdul ansari
International Journal of Infectious Diseases, 2021
View PDFchevron_right
Use of favipiravir against Covid-19: A Review
eiman syed
Pakistan BioMedical Journal, 2022
View PDFchevron_right